PNPLA3 and Cirrhosis: Singal et al. performed a meta-analysis of nine studies with 2937 patients and found that PNPLA3 was associated with an increased risk of HCC in patients with cirrhosis (OR 1.40, 95% CI 1.12–1.75) [91].